Published in J Clin Endocrinol Metab on May 08, 2007
Acute myocardial infarction as the first presentation of thyrotoxicosis in a 31-year old woman - case report. Thyroid Res (2010) 0.86
Sinus sigmoideus thrombosis secondary to graves' disease: a case description. Case Rep Neurol (2011) 0.77
Procoagulant and anticoagulant factors in childhood hypothyroidism. Int J Endocrinol (2012) 0.75
Metabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study. Thyroid Res (2008) 0.75
Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes. Heart Fail Rev (2016) 0.75
Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders. Int J Endocrinol Metab (2017) 0.75
Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. Am Heart J (2008) 3.05
Sedation in screening colonoscopy: impact on quality indicators and complications. Am J Gastroenterol (2012) 2.97
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. J Hepatol (2012) 2.93
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. N Engl J Med (2016) 2.83
von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis. Hepatology (2012) 2.36
von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation (2008) 2.20
Calcium-channel blockers reduce the antiplatelet effect of clopidogrel. J Am Coll Cardiol (2008) 2.10
Challenges with advanced therapy medicinal products and how to meet them. Nat Rev Drug Discov (2010) 2.09
Effects of carbon monoxide inhalation during experimental endotoxemia in humans. Am J Respir Crit Care Med (2004) 1.98
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut (2012) 1.83
Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood (2004) 1.82
Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection. Clin Gastroenterol Hepatol (2011) 1.70
Platelet dysfunction in outpatients with left ventricular assist devices. Ann Thorac Surg (2009) 1.68
A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler Thromb Vasc Biol (2006) 1.54
Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Heart (2010) 1.53
The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma. J Invest Dermatol (2006) 1.52
Hemostasis in cardiac arrest patients treated with mild hypothermia initiated by cold fluids. Resuscitation (2009) 1.49
Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation. Thromb Res (2008) 1.48
Effect of fortifiers and additional protein on the osmolarity of human milk: is it still safe for the premature infant? J Pediatr Gastroenterol Nutr (2013) 1.47
Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans. Thromb Haemost (2003) 1.46
In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun (2009) 1.45
Human monocyte stimulation by experimental whole body hyperthermia. Wien Klin Wochenschr (2002) 1.43
Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy. Crit Care Med (2010) 1.42
The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia. Thromb Haemost (2005) 1.40
Pronounced platelet hyperfunction in patients with cardiac arrest achieving restoration of spontaneous circulation. Crit Care Med (2009) 1.40
Vitamin D status and its relation to age and body mass index. Horm Res (2006) 1.35
Relationship between serum lipoprotein ratios and insulin resistance in obesity. Clin Chem (2004) 1.25
Duffy antigen modifies the chemokine response in human endotoxemia. Crit Care Med (2008) 1.20
Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia. Crit Care Med (2004) 1.18
Acoustic Radiation Force Impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study. Eur J Radiol (2012) 1.18
Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation (2004) 1.16
Endotoxemia, inflammation, and atrial fibrillation. Am J Cardiol (2007) 1.16
Plasma protein profiling: unique and stable features of individuals. Proteomics (2005) 1.11
Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects. Vaccine (2006) 1.11
Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation. Thromb Haemost (2005) 1.10
Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate. Eur J Nucl Med Mol Imaging (2004) 1.09
Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteers. Transfusion (2013) 1.07
Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization. Clin Endocrinol (Oxf) (2003) 1.07
Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH). Clin Endocrinol (Oxf) (2008) 1.05
Thrombin as a multi-functional enzyme. Focus on in vitro and in vivo effects. Thromb Haemost (2011) 1.05
Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases. Br J Pharmacol (2009) 1.05
Interspecies differences in coagulation profile. Thromb Haemost (2008) 1.04
Thyroid ultrasound versus antithyroid peroxidase antibody determination: a cohort study of four hundred fifty-one subjects. Thyroid (2002) 1.04
Thyrotropin serum concentrations in patients with papillary thyroid microcancers. Thyroid (2010) 1.02
Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience. Wien Klin Wochenschr (2012) 1.00
Endotoxaemia modulates Toll-like receptors on leucocytes in humans. Br J Haematol (2003) 1.00
Ethnic differences in plasma levels of interleukin-8 (IL-8) and granulocyte colony stimulating factor (G-CSF). Transl Res (2007) 0.99
Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C. Vaccine (2009) 0.97
Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion. Atherosclerosis (2007) 0.95
New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension. Liver Int (2014) 0.94
Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51. Vaccine (2011) 0.94
Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients. Vaccine (2007) 0.93
Expression of the high-affinity IgG receptor FcRI (CD64) in patients with inflammatory bowel disease: a new biomarker for gastroenterologic diagnostics. Am J Gastroenterol (2009) 0.93
Renal elimination of sclerostin increases with declining kidney function. J Clin Endocrinol Metab (2013) 0.93
Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trial. Thromb Haemost (2011) 0.93
Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wien Klin Wochenschr (2013) 0.93
Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants. Pediatrics (2006) 0.92
Personalized antiplatelet treatment after percutaneous coronary intervention: the MADONNA study. Int J Cardiol (2012) 0.92
Anti-von Willebrand factor aptamer ARC1779 for refractory thrombotic thrombocytopenic purpura. Transfusion (2009) 0.92
Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura. Am J Hematol (2012) 0.91
Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection. Inflamm Bowel Dis (2010) 0.91
The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia. Clin Chem (2005) 0.91
A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity. Pediatrics (2006) 0.91
O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease. J Proteome Res (2009) 0.90
Surface cooling for induction of mild hypothermia in conscious healthy volunteers - a feasibility trial. Crit Care (2011) 0.90
Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine. Vaccine (2010) 0.89
Small volume enemas do not accelerate meconium evacuation in very low birth weight infants. J Pediatr Gastroenterol Nutr (2007) 0.89
Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin. Int J Cardiol (2012) 0.88
Volumetric intravascular ultrasound imaging to illustrate the extent of coronary plaque burden in type 2 diabetic patients. J Diabetes Complications (2007) 0.88
Regulation of Fas (APO-1, CD95) and Fas ligand expression in leukocytes during systemic inflammation in humans. Shock (2003) 0.88
Effect of factor X inhibition on coagulation activation and cytokine induction in human systemic inflammation. J Infect Dis (2002) 0.88
Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients. AIDS (2013) 0.87
Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia. Clin Pharmacol Ther (2006) 0.87
MMP-8 genotypes influence the inflammatory response in human endotoxemia. Inflammation (2014) 0.86
Targeting von Willebrand factor and platelet glycoprotein Ib receptor. Expert Rev Cardiovasc Ther (2010) 0.86
The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo. Transfusion (2010) 0.86
A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura. Thromb Haemost (2011) 0.86
The C-reactive protein (+)1444C/T alteration modulates the inflammation and coagulation response in human endotoxemia. Clin Chem (2006) 0.86
Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3. Liver Int (2014) 0.86
Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura. Thromb Haemost (2010) 0.86
Cross validation of the Multiple Electrode Aggregometry. A prospective trial in healthy volunteers. Thromb Haemost (2009) 0.85
Evaluation of coagulation markers for early diagnosis of acute coronary syndromes in the emergency room. Clin Chem (2002) 0.85
The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction. Platelets (2009) 0.85
Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters. Obes Surg (2012) 0.84
Why have studies of tailored anti-platelet therapy failed so far? Thromb Haemost (2013) 0.84
Levothyroxine replacement in hypothyroid humans reduces myocardial lipid load and improves cardiac function. J Clin Endocrinol Metab (2014) 0.84
ARC15105 is a potent antagonist of von Willebrand factor mediated platelet activation and adhesion. Arterioscler Thromb Vasc Biol (2012) 0.84
The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease. Thromb Haemost (2012) 0.84
Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Ann Thorac Surg (2011) 0.84
A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate. Clin Exp Rheumatol (2012) 0.84
Angiotensin receptor blockade decreases markers of vascular inflammation. J Cardiovasc Pharmacol (2004) 0.84
Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity. Thromb Haemost (2005) 0.83
The interleukin-6 G(-174)C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans. Clin Chem (2004) 0.83
The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis. Clin Exp Rheumatol (2011) 0.83
In-vivo effects of simvastatin and rosuvastatin on global gene expression in peripheral blood leucocytes in a human inflammation model. Pharmacogenet Genomics (2008) 0.83